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Abstract 
DNA polymerase I employs a multistep mechanism for sorting correctly paired 
nucleotides from mismatches.  We aim to characterize reaction intermediates during 
nucleotide selection to better understand how this class of enzymes achieves high DNA 
replication fidelity.  DNA polymerase I from R. marinus contains an unusual and 
disruptive proline in the mobile O helix near the active site.  To characterize this 
enzyme, the structure of the large (5´-to-3´ exo-deficient) fragment of the R. marinus 
DNA polymerase I (RF) was solved to 2.95 Å (R = 0.234) using multi-wavelength 
anomalous dispersion.  Alignment with homologous Escherichia coli Klenow Fragment 
(KF) DNA polymerase I confirmed that the active sites of each structural domain were 
conserved.  In order to study the polymerase activity in isolation, 3’-to-5’ exonuclease 
activity was eliminated using site-directed mutagenesis of an aspartic acid involved in 
binding DNA (D497A).  Unexpectedly, mutation of an aspartic acid involved in binding a 
catalytic magnesium ion (D421A in RF) failed to abolish exonuclease activity despite its 
ability to do so in the KF (D424A).  Future structural studies will include crystallization of 
the polymerase in both its binary and ternary complex to study the conformational 
changes associated with the process of nucleotide selection as well as examination of 
the exonuclease domain to characterize its unusual activity in this enzyme.
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I. Background 
DNA polymerases are responsible for DNA synthesis, the reaction that copies genetic 
material. These enzymes have been classified into seven distinct families: A, B, C, D, X,  Y 
and RT 1.  Within the Family A of polymerases is DNA polymerase I, the first polymerase 
to ever be identified, and the most abundant of DNA polymerases within Escherichia 
coli2. Within bacteria, DNA polymerase I actively participates in processing Okasaki 
fragments generated during lagging strand synthesis by removing RNA primers to fill in 
the gaps, and maintains the high fidelity of replication by performing nucleotide excision 
repair1. 
 DNA Polymerases are characterized by a multi-domain structure consisting of 
polymerase activity as well as 3’-5’ and/or 5’-3’ exonuclease activity (Figure 1)3.  
 
Figure 1. Bacillus Fragment DNA Polymerase I (apo form). Numbered regions are (1) Fingers region, (2) 
Palm region, and (3) Thumb region of the polymerase domain, and (4) 3’-5’ exonuclease domain [PDB ID: 
1XWL]. 
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The polymerase domain is responsible for performing DNA synthesis, the 3’-5’ 
exonuclease domain has a proofreading function and performs nucleotide excision 
repair, and the 5’-3’ exonuclease domain removes RNA primers for the filling in of 
Okasaki fragments1. The polymerase domain is often likened to a right hand in that it 
contains palm, fingers, and thumb motifs that aid in the binding of DNA4 (Figure 1).   The 
“palm” domain grasps the nascent template DNA5,6. The finger motif consists of many 
helices that serve as key contributors to the catalytic cleft in this domain7. Mutation of 
key residues in one helix, the O-helix, demonstrated the importance of this secondary 
structure as a deoxyribonucleotide phosphate (dNTP) binding cleft7. For high-fidelity 
bacterial DNA polymerase I enzymes, the template base is flipped out of the DNA base 
stack and resides in a “pre-insertion site” prior to encountering a free dNTP. Preliminary 
models suggested that binding of a nucleotide substrate induces a change in the 
structure of the enzyme from an open state to a closed state8. As seen in multiple 
experimental systems, the active site O-helix rotates greater than 40° towards the 
catalytic site upon binding a nucleotide complementary to the template base9. Below, 
Figure 2 depicts DNA polymerase I from Bacillus Stearothermophilus (Bacillus Fragment, 
BF) adopting both the open and closed conformations in the presence of a DNA 
substrate. The blue helix represents the mobile O-helix in the active site that serves as a 
gating structure during nucleotide selection. Enclosure of the nucleotide opposite the 
template base forms an “insertion site” in which the dNTP undergoes in-line 
nucleophilic attack by the 3’-hydroxyl of the primer, which results in the formation of a 
phosphodiester bond concomitant with pyrophosphate cleavage from the 
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nucleotide5,9,10,11,12,13 (Figure 3).  Once the pyrophosphate is released, the fingers 
domain opens, and polymerase transitions to the next nucleotide for another round of 
nucleotide incorporation.  
 
 
Figure 2. Bacillus Fragment DNA Polymerase I bound to DNA in (a) Open and (b) Closed Conformations. 
Bacillus Fragment bound to DNA substrate (gray) transitions from (a) open conformation [PDB ID: 1L3S] to 
(b) closed conformation [PDB ID: 2HVI] through movement of mobile O-helix (blue).   
 
Figure 3. The two-metal ion mechanism of DNA polymerase.The active site features two metal ions that 
stabilize the resulting pentacoordinated transition state. Metal ion A activates the primer’s 3′-OH for 
attack on the α-phosphate of the dNTP. Metal ion B plays the dual role of stabilizing the negative charge 
that builds up on the leaving oxygen and chelating the β- and γ-phosphates. Figure and caption 
reproduced from Figure 3, Reference 13. 
(a) (b) 
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While matching complementary nucleotides with templates bases, the mismatch 
frequency of these enzymes varies from one in five thousand to one in one million 
nucleotides14. DNA polymerases are thought to exhibit extremely high fidelity by 
utilizing hydrogen bonding, active site water exclusion, geometric selection, and 
conformational checkpoints for sorting correctly paired base pairs14. Although much is 
known about the open and closed conformational changes of the enzyme in the 
reaction pathway, the steps in between are not well characterized. Determining these 
reaction intermediates or “kinetic checkpoints” allows us to understand how these 
enzymes achieve such a high level of fidelity throughout the process of nucleotide 
selection. While studying the enzyme’s reaction pathway, the rate-limiting step of dNTP 
insertion was found to be a non-covalent process that precedes chemical bond 
formation (see references from review)15.  However, when and how this process occurs 
has remained unclear. Many models have been proposed describing this non-covalent 
process. One model posits that the closed conformation is the rate-limiting step, and 
that one or more conformational changes allow the dNTP to “preview” the template 
base in the open conformation15. A complementary dNTP would stabilize the binding 
interaction, and would favor the formation of the closed complex, while a 
noncomplementary dNTP would favor dissocation15. Below is a theoretical schematic of 





Figure 4. Schematic of Nucleotide Selection. Polymerase (Eo) bound to DNA binds dNTP in fast 
equilibrium step, undergoes conformational rearrangement (Eo-DNA*-dNTP), and then goes from open to 
closed conformation (Ec)in a slow, rate-limiting step. Pyrophosphate release (PPi) from the complex marks 
the formation of a phosphodiester bond and the end of one round of nucleotide incorporation. 
Reproduced from Figure 2, Reference 15.  
This model has been supported by many experimental studies. For example, a study in 
DNA polymerase I from Thermus aquaticus indicated that there is a step prior to dNTP 
binding that is dependent on the incoming nucleotide and precedes the closed 
conformation16. Another study in the Klenow Fragment (KF) isolated from E.coli  
demonstrated that mismatched nucleotides were discriminated against in the reaction 
pathway prior to the fingers closing, suggesting that selection against mismatched 
nucleotides occurs at an uncharacterized, earlier step17.  
Recently, an X ray crystal structure of a mismatched base pair in the active site of a DNA 
polymerase I from Bacillus Fragment revealed that the enzyme did not proceed directly 
to the closed conformation18. Instead, the polymerase established an intermediate 
conformation, called the “ajar” conformation, in which the template base had moved 
into the insertion site but misaligned the incorrect nucleotide. This ajar conformation 
was characterized as adopting elements characteristic of both the open and closed 
conformations; the mobile O, O1, and N helices in the active site all retained structural 
similarity to the open conformation while the C-terminal helical turn of the O-helix 
resembled the closed conformation. This portion of the O-helix was different in that a 
     +dNTP Eo-DNA Eo-DNA-dNTP Eo-DNA*-dNTP Ec-DNA*-dNTP Ec-DNA*-PPi   fast   
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conserved active site tyrosine was displaced, thereby unraveling the end of the O-helix 
and moving the O-helix in a position intermediate to that of the open and closed 
conformations. The study used these structural findings to hypothesize that the ajar 
conformation is the missing “preview” checkpoint during which the template probes 
incoming nucleotides for complementarity before proceeding to the closed 
conformation18. The schematic below represents the theorized process of nucleotide 
binding and nucleotide selection as the enzyme proceeds from the open to the ajar 
conformation, and finally to the closed conformation if the incoming nucleotide is 
complementary (Figure 5, reproduced from Reference 18, with permission).  
 
Figure 5. Schematic representation of Open, Ajar, and Closed states, respectively. The ajar conformation 
resembles the Eo-DNA*-dNTP complex described in Figure 3.   
Although experimental data corroborates the existence of this  
preview checkpoint in BF, it would be useful to observe the ajar conformation in other 
polymerases of the same class. By catching them adopting this transitional ajar 
conformation, biochemists would be able to ascertain valuable information about the 
process of nucleotide selection, and possibly observe other unseen intermediates in the 
DNA synthesis reaction.  
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II. Introduction 
Rhodothermus marinus is a gram-negative, thermophilic eubacterium found in the 
alkaline environment of submarine hot springs19. It is an obligate aerobe that grows 
optimally at 65 °C and pH 7.0 in 2% sodium chloride. The R. marinus DNA polymerase I 
has 43% sequence identity with the Pol I sequences of E. coli and B. 
stearothermophilus19. This polymerase consists of 5’-3’ and 3’-5’ exonuclease domains 
as well as a polymerase domain. In addition, it was observed that a highly conserved 
phenylalanine residue in the O-helix of E. coli Pol I has been naturally substituted with a 
tyrosine at position 757 in the R.marinus Pol I. This polymerase and others with this 
substitution are able to incorporate dideoxynucleotides (ddNTPs) with high efficiency, 
making this polymerase useful for applications in biotechnology, such as DNA 
sequencing.  
This enzyme is particularly interesting because it contains a proline residue at the 
beginning of mobile O-helix, a natural substitution from isoleucine and valine seen in KF 
and BF, respectively (Figure 6)19.  
 
Figure 6. Polymerase domain active site sequence alignment of RF, KF, and BF.  
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When the study that characterized the ajar conformation mutated the valine residue in 
BF to a proline residue (V713P), they found that they were able to stabilize the ajar 
conformation and examine it in the presence of a complementary nucleotide18. 
Moreover, it was discovered that the proline mutation blocked the formation of a 
hydrogen bond between the carbonyl residue 709 and the backbone nitrogen of residue 
713, and that it sterically hindered the formation of a contiguous O-helix. The V713P 
mutant was found to be slower than the wild-type BF when incorporating either the 
correct or incorrect nucleotide. Additionally, the rate of catalysis for V713P was slower 
in the presence of a mismatch than when in the presence of a correct nucleotide, 
indicating that both reaction pathways adopt the ajar conformation before transitioning 
to either the open state to release the mismatched dNTP or to the closed state to 
continue with nucleotide incorporation. Based on the information garnered from the BF 
study, and due to the fact that RF contains a natural proline substitution in place of 
valine in the polymerase active site, R. marinus DNA polymerase I appears to be a 
candidate that may preferentially adopt the ajar conformation.  
In order to observe the conformational changes of the Rhodothermus Fragment (RF) in 
the presence of a DNA substrate, and correct or incorrect nucleotides, we aim to utilize 
X-ray crystallography to obtain atomic resolution structures of the enzyme in various 
stages of the reaction pathway. The aims of this study were three-fold: solving the 
structure of the apo form of RF, of RF in its binary complex with a DNA substrate, and of 
RF in its ternary complex with DNA and in the presence of correct/incorrect nucleotides. 
Studying these three forms of the polymerase would allow us to visualize the 
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conformational changes that it undergoes at an atomic level, and would identify 
whether it adopts the ajar conformation during nucleotide selection. Understanding this 
process would not only contribute to a greater understanding of the DNA synthesis 
reaction, but it would also allow for the application of this newly garnered information 
to improving biosynthesis reactions in the field of biotechnology. 
In the present study, we describe the 2.95 Å resolution structure of the large (5’-3’ 
exonuclease deficient) Rhodothermus Fragment (RF) containing a mutation (D421A) in 
active site of the 3’-5’ exonuclease domain, solved using the Multiwavelength 
Anomalous Dispersion (MAD) method. MAD is a method used in X-ray crystallography to 
aid in the determination of a three-dimensional atomic resolution structure. X-ray 
crystallography involves bombarding a crystallized molecule with X-rays, and then 
detecting the scattered radiation from the electron clouds of atoms in the crystal lattice 
to produce a diffraction pattern20. This diffraction pattern yields information regarding 
the amplitude of the diffracted rays, but not their relative phases. In order to generate 
an electron density map of a molecule, the phases of the diffracted rays must be 
determined. The MAD method involves the incorporation of heavy atoms, such as 
selenomethionine, into the molecule of interest so that when bombarded with varying 
wavelengths of X-rays, the resonance centers of the heavy atoms produce unique 
scattering patterns that yield the phases of the diffracted rays20. Once the phases have 
been determined, an electron density map is generated for use in model building and 
structure determination.  
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III. Results 
A. Overall structure 
The D421A RF protein was crystallized in space group P212121, an orthorhombic unit cell 
with α, β, γ dimensions of 90 Å (Table 1).  
Table 1. Data collection, phasing, and refining statistics. 
 
The resulting structure was solved to 2.95 Å using MAD, and had R-free and R-factor 
values of 0.292 and 0.234, respectively (Table 1, Figure 7). The root mean square 
deviations (r.m.s.d) bond length and bond angles were 0.0080 Å and 1.21, respectively. 
The Ramachandran plot showed that 92.1% of residues were in the favored region while 
98.8% of residues were in the allowed regions of the plot. Residues 569-607, which 
correspond to the tip of the thumb motif within the polymerase domain, were omitted 
from the structure due to poor electron density.  
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Figure 7. Ribbon representation of apo D421A RF solved at 2.95 Å. (1) Fingers Domain, (2) Palm Domain, 
(3) Thumb Domain, and (4) 3’5’ exonuclease domain. Dotted line depicts missing region of thumb motif.  
 
Figure 8. Polymerase active site structural alignment of apo RF (pink) and apo KF (gray). Residues P760 
in RF and I765 in KF mark the C-terminal end of the mobile O-helix. Residues Y757 in RF and F762 in KF are 
shown to demonstrate natural substitution of conserved  phenylalanine residue to tyrosine in RF.  
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Active site sequence and structural alignments of the polymerase domains in RF and KF 
demonstrated that mobile O helices were conserved in both sequence and structure, 
with the exception of P760 and Y757 (Figure 6, 8). Active site sequence and structural 
alignment of the 3’-5’ exonuclease domains in RF and KF demonstrated that catalytically 
important amino acid residues were conserved between the two species (Figure 9). 
Mutation of 3’-5’ exonuclease active site acidic residues in KF have been shown to 
decrease exonuclease activity by several orders of magnitude21.  
 
Figure 9a. 3'-5' exonuclease domain active site sequence alignment and 9b. 3'-5' exonuclease domain 
active site structural alignment in RF (pink) and KF (gray). Highlighted residues in red (9a.) represent 
conservation of amino acids essential for exonuclease activity in RF and KF. Same residues are depicted in 
structural alignment (9b.), with the exception of D421A mutation in RF. Electron density (green) is shown 




B. 3’ to 5’ Exonuclease Domain 
DNA polymerase I is able to retain polymerase activity in the absence of a 5’-3’ 
exonuclease domain. Therefore, the large fragment (5’-3’ exo deficient) was used for 
crystallization, and site-directed mutagenesis (D421A) was utilized to inactivate the 3’-5’ 
exonuclease domain of RF for future kinetic studies and co-crystallization trials. To assay 
exonuclease inactivation, a double-stranded DNA substrate containing 2-aminopurine 
(2-AP), an environmentally sensitive fluorophore, was bound to RF and its mutants. 
When base paired to thymine, 2-AP fluorescence is quenched. When the primer is in 
position “X-1” fluorescence is low, in position “X” fluorescence is high and in position 
“X+1” fluorescence decreases to an intermediate level (Figure 10)22.  
 
Figure 10. Double-stranded DNA Template used for 2-Aminopurine assay. Labeled in red are the 
positions that 2-AP will adopt as a result of exonuclease activity. When quenched at position (X-1), (X), 
and (X+1), 2-AP emits low, high, and intermediate levels of fluorescence, respectively. 
 
The 2-Aminopurine fluorescence assay revealed that both wild-type RF and D421A had 
similar 3’-5’ exonuclease activity as demonstrated by the sharp increase to a high level 
of fluorescence followed by a decrease to an intermediate level of fluorescence (Figure 
11). Site-directed mutagenesis was utilized to make another mutant by changing a 
14  
separate single amino acid residue (D497A) in RF, and the 2-AP fluorescence assay 
revealed an initial slight change in fluorescence followed by a constant level of 
fluorescence for the remainder of the time period (Figure 11).  
 
Figure 11. 2-AP Fluorescence Assay of RF, D421A RF and D497A RF. 3’-5’ exonuclease activity in RF, 
D421A RF, and D497A RF was measured using 10ntPrimer+2-AP-11ntTemplate DNA. Fluorescence was 
measured over a 10-minute time course at 10 second intervals. The increase in fluorescence to an 
intensity of 80 most likely represents the binding event of protein to DNA.        
15  
IV. Discussion 
A. Overall Structure 
The overall structure of the Rhodothermus Fragment (RF) is similar to previously 
reported polymerases such as the Klenow Fragment (KF) and Bacillus Fragment (BF). 
DNA polymerase I consists of three structural domains: one that catalyzes DNA synthesis 
(polymerase domain), one that catalyzes proofreading and nucleotide excision repair 
(3’-5’ exonuclease domain) of the synthesized DNA strand, and one that removes the 
RNA primers on Okasaki fragments (5’-3’ exonuclease domain). Because the structure of 
the 5’-3’ exonuclease deficient RF was solved, only the 3’-5’ exonuclease domain and 
polymerase domain are depicted in the ribbon representation of RF (Figure 7). The top 
portion “claw-like” portion of the structure represents the polymerase domain (labeled 
1-3) while the bottom portion is the exonuclease domain (labeled 4). As seen with other 
DNA polymerase I structures without DNA, the thumb tip is flexible and difficult to 
visualize in the crystal structure. Co-crystallization of RF with a DNA substrate should 
allow us to build in the missing region, as a substrate would stabilize this region that is 
solvent-exposed in the open conformation. The thumb has been shown to interact with 
DNA in other DNA polymerases and change its conformation when bound.  
Active site structural alignment of RF and KF confirmed the natural substitution of the 
phenylalanine residue to tyrosine (F762 in KF and Y757 in RF) and isoleucine residue to 
proline (I765 in KF and P760 in KF) in the active site of RF (Figure 8). Both exonuclease 
active site sequence and structural alignment demonstrated that amino acid residues 
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deemed essential for the exonuclease reaction in KF (D355, E357, D501, and D424) are 
conserved in RF (Figures 9)21. Based on these structural observations, we hypothesize 
that both the polymerase and exonuclease activity of this enzyme should operate by a 
reaction mechanism similar to KF and BF. 
B. 3’ to 5’ Exonuclease Domain 
Crystallographic studies of the exonuclease domain in KF have demonstrated that the 
product and inhibitor of the exonuclease reaction, deoxynucleoside monosphosphate 
(dNMP), binds to the active site of the 3’-5’ domain23. Studies have also demonstrated 
that the presence of two divalent metal ions is crucial for binding the substrate and 
catalysis of the exonuclease reaction. A structural model of the KF exonuclease active 
site with a bound dNMP and metal ions has indicated that the phosphate oxygen atoms 
of dNMP interact with one metal ion bound to the protein by three amino acids—two 
aspartic acids, Asp355 and Asp501, and one glutamic acid, Glu357 (Figure 12, 
reproduced from Reference 23).  
 
Figure 12. KF 3’-5’ exonuclease active site. Deoxycytidine monophosphate (dCMP) is shown with 
thickened bonds, and side chains of active site residues are shown interacting with metal ions (labeled A 
and B) and dCMP. Reproduced from Figure 1, Reference 23.  
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The second metal ion lies adjacent to an aspartic acid, Asp424, only when the dNMP is 
bound, and shares Asp355 only when the first metal is bound21. Mutations to each of 
these amino acid residues have shown that exonuclease activity drastically decreased by 
at least four orders of magnitude, indicating that they are crucial to this reaction21. A 
mutation of Asp424 to alanine (D424A) in KF reported the largest decrease in 
exonuclease activity, followed by a mutation to Asp501 (D501A)21. In this study, we 
made a mutation in RF (D421A) that corresponded to the D424A mutation in KF in order 
to eliminate 3’-5’ exonuclease activity. In spite of this mutation, a 2-AP fluorescence 
assay demonstrated that the D421A RF exonuclease activity was just as active as the 
wild-type exonuclease activity (Figure 11). This is peculiar in that this aspartic acid was 
demonstrated to chelate the second metal ion required for exonuclease catalysis; 
therefore, mutation of this residue should have prevented catalysis of this reaction. 
After making a separate second mutation (D497A) in RF that corresponded to the D501A 
mutation in KF, a 2-AP fluorescence assay demonstrated that exonuclease activity was 
abolished in this mutant. Although we have not been able to determine why the D421A 
RF mutant is still active, we hope to explore this question in future structural studies. 
The D497A mutant is currently being used for kinetic analysis as well as for co-
crystallization trials. 
In conclusion, the atomic resolution structure of the D421A, 5’3’ exonuclease 
deficient DNA polymerase I isolated from Rhodothermus marinus has been solved to 
2.95 Å. Structural analysis has demonstrated that key amino acids at the active sites of 
both the polymerase and exonuclease domains of the polymerase are conserved with 
18  
other well-characterized polymerases such as the Bacillus and Klenow Fragments. Upon 
closer study of two RF mutants, one with D421A and another with D497A, which contain 
single amino acid mutations to acidic amino acids in the exonuclease active site, it was 
found that D421A RF 3’-5’ exonuclease activity was similar to the wild-type RF, and that 
D497A RF lacked any inherent exonuclease activity. Future studies include crystallization 
of the polymerase in its binary and ternary complexes to study the conformational 
changes associated with nucleotide selection, and additional structural analysis of the 
exonuclease domains of wild-type RF and its mutants. Information garnered from these 
studies will allow us to characterize previously unseen reaction intermediates in the 
DNA replication pathway, and will provide useful information on how to improve these 












DNA fragment encoding the 5’-‘3 exonuclease deficient Rhodothermus Fragment (RF) 
was amplified by PCR, and inserted into pCR2.1-TOPO vector (Invitrogen) as EcoRI 
restriction-enzyme fragment. Oligonucleotides used for amplification were (5’-3’) 
CATATGGAAAAGGCGGACTACCGGATCGTC and TCAGTGGGCATCCAGCCAGTTG-TC. Gene 
was sequenced using Sanger sequencing and inserted into bacterial expression vector, 
pET-21a (Novagen) as BamHI-NdeI restriction-enzyme fragments.  
 
B. Site-Directed Mutagenesis: D421A 
The D421A mutation was generated using the QuikChange site-directed mutagenesis kit 
(Stratagene) with Phusion High-Fidelity DNA Polymerase (NEB).  The oligonucletoides 




C. Selenomethionine protein labeling, expression and purification 
The pET-21a plasmid containing the gene of interest was transformed into Escherichia 
coli B834(DE3) cells (Novagen, methionine auxotroph). Cells were cultured overnight 
with shaking at 37 °C in 60 mL Starter Media (Minimal Media + 5% LB) containing 
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ammonium sulfate (1 g/L), potassium dihydrogen phosphate (4.5 g/L), potassium 
phosphate (10.5 g/L), sodium citrate (0.5 g/L), amino acids (19 L-amino acids, no 
methionine; 0.8 g/L), nucleotide mix, glucose (0.5% w/v), magnesium sulfate (1 mM), 
thiamine (4 mg/mL), d-biotin (4 mg/mL), L-selenomethionine (30 mg/mL),  ampicillin 
(100 mg/mL), and Luria-Bertani broth (5%). Inoculated  500 mL Minimal Media with 20 
mL overnight culture and grew at 37 °C to OD600=0.400. Expression of selenomethionine 
labeled protein was induced with IPTG (5 mM) and the cells were incubated overnight at 
37°C. Cells were harvested by centrifugation at 4000 RPM for 15 minutes, and stored at 
4 °C.  
A bacterial pellet from cell culture was resuspended and lysed in B-PER (Bacterial 
Protein Extraction Reagent 20 mM Tris Buffer, pH 7.5; Pierce). Lysate was centrifuged at 
7500 RPM for 30 minutes and supernatant was heated in 65 °C water bath for 20 
minutes. Lysates were centrifuged again at 7500 RPM for 30 minutes, and supernatant 
was dialyzed in 1x Buffer A (50 mM Tris HCl pH 7.5, 1 mM EDTA, 6.5 mM BME). 
Supernatant was passed through heparin sepharose column equilibrated in 1x Buffer A 
using a linear gradient containing 1x Buffer A and 50% 1x Buffer A & 1.5 M sodium 
chloride (Buffer B). Fractions containing the protein were collected and exchanged back 
into 1x Buffer A through dialysis. The fractions were then passed through S1 ion 
exchange column (BioRad) pre-equlibrated with 1x Buffer A using a linear gradient 
containing 1x Buffer A and 1x Buffer B. Fractions containing protein were combined and 
concentrated using 10 kDa Amicron centrifugal concentrators (Millipore).  Protein 
sample was run through S1 ion-exchange column again to remove remaining impurities, 
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again using linear gradient of 1x Buffer A and 1x Buffer B. Fractions containing RF were 
exchanged into 1x Buffer A through three cycles of concentration and dilution, and 
concentrated to 1 mL in 50 kDa Amicron centrifugal concentrator (Millipore).  
 
D. Protein crystallization 
Crystallization trials were set up in 96-well trays using PEG/Ion HT and Crystal Screen HT 
commercial screens (Hampton Research). D421A RF crystals were obtained in 20% w/v 
Polyethylene glycol 3350, 0.2 M Potassium thiocyanate at 17 °C using a protein 
concentration of 100 µM. Optimization of crystallization conditions was carried out by 
hanging drop vapor diffusion using a 2% gradient of 10-20% PEG 3350, 0.2 M Potassium 
thiocyanate. Crystals with average dimensions of 150 x 150 x 500 µM were grown by 
mixing 1 µl protein solution with 1 µl reservoir solution (18% PEG 3350, 0.2 M Potassium 
thiocyanate) and incubating at 17 °C for 5-7 days. Crystal was harvested with nylon 
cryoloop and transferred into 10 µl drop of 18% PEG 3350, 0.2 M Potassium 
thiocyanate.  Crystal was cryoprotected by adding 18% PEG 3350, 0.2 M Potassium 
thiocyanate and 50% Ethylene glycol four times to the drop until final concentration of 






E. Data collection, structure determination and refinement 
Multiwavelength anomalous dispersion data for a SeMet derivative crystal was collected 
at radiation wavelengths of 0.97926, 0.97943, and 0.97481 Å at the Advanced Photon 
Source at U.S. Department of Energy’s Argonne National Laboratory, using beamline 22-
ID-D at -173 °C with a MAR 300-mm CCD. All diffraction data were indexed, integrated 
and scaled with XDS.  
The crystal structure of RF was determined using the MAD phasing method from a 
SeMet-substituted protein crystal to a maximum resolution of 2.95 Å. The PHENIX 
program suite was used to locate 16 selenium atoms and for phasing. Multiple rounds of 
iterative model building and refinement were performed using Coot and REFMAC5; 5% 
of the data were excluded from modification and used for cross-validation. Geometry of 
the structure was analyzed using MolProbity.  
 
F. Site-Directed Mutagenesis: D497A 
The D497A mutation was generated using the QuikChange site-directed mutagenesis kit 
(Stratagene) with Phusion High-Fidelity DNA Polymerase (NEB). The oligonucletoides 
used for the mutagenesis reaction were (5’-3’) CCCTATGCCTGT GAA GCC ACGGACATT 




G. 2-Aminopurine (2-AP) Fluorescence Assay 
Fluorescence assay using a 2-AP tagged DNA substrate was utilized for detecting RF 
exonuclease activity. The oligonucleotides used for the assay were (5’-3’) GCCGCGTCCT 
and T[2AmPur]GGACGCGGC. Protein mixed with DNA was excited at 313 nm and an 
emission spectrum was collected at 360 nm over a 10 minute time course at 10 second 
intervals using the JASCO FP-6200 spectrofluorometer. This assay was conducted for the 
wild-type protein as well as the D421A and D497A mutants.  
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